Hannes Sabine, Reinisch Alexander, Bechstein Wolf O, Habbe Nils
Department of General and Visceral Surgery, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.
Int J Colorectal Dis. 2016 Mar;31(3):653-9. doi: 10.1007/s00384-015-2474-5. Epub 2015 Dec 21.
Squamous cell cancer of the anus (SCCA) is a rare disease of the gastrointestinal tract. Even though chemoradiation therapy is the treatment of choice, a substantial number of patients develop recurrent cancers or present with persisting SCCA. Therefore, abdominoperineal excisions as a salvage therapy are the only chance of cure.
Hospital files of all patients with recurrent squamous cell carcinoma of the anus who underwent abdominoperineal excision performed at the Department of General and Visceral Surgery of the University Hospital Frankfurt between January 2003 and December 2013 were retrospectively reviewed.
Fourteen (nine males, five females) patients underwent abdominoperineal resections for recurrent SCCA. In six patients, the pelvic floor was closed by direct suture, four patients underwent reconstruction using a vertical rectus abdominis myocutaneous (VRAM) flap, and four patients received a gluteal myocutaneous flap. Patients receiving flap-mediated closure revealed a median hospital stay of 26 days (range 13-60 days) compared to 11 days (range 9-30 days) in patients with direct closure (p = 0.01). Two patients (14%) suffered from wound infections (Dindo-Clavien II), whereas three patients (21%) underwent up to seven reoperations for breakdown of their wounds and/or laparotomies (Dindo-Clavien IIIb). The calculated 5-year survival rate was 86%. Patients with rpT0/T1 stage had a significantly longer survival compared to patients presenting with rpT2/T3/T4 tumors.
Abdominoperineal excisions in patients with recurrent SCCA can provide long-term local control and survival. The complication rate is not associated with the closure technique employed, but patients undergoing flap-mediated closure revealed a significantly longer hospital stay.
肛管鳞状细胞癌(SCCA)是一种罕见的胃肠道疾病。尽管放化疗是首选治疗方法,但仍有相当数量的患者会出现复发性癌症或持续性SCCA。因此,腹会阴联合切除术作为挽救性治疗是唯一的治愈机会。
回顾性分析了2003年1月至2013年12月在法兰克福大学医院普通外科和内脏外科接受腹会阴联合切除术的所有复发性肛管鳞状细胞癌患者的医院病历。
14例(9例男性,5例女性)患者因复发性SCCA接受了腹会阴联合切除术。6例患者通过直接缝合关闭盆底,4例患者采用腹直肌肌皮瓣(VRAM)进行重建,4例患者接受臀肌肌皮瓣。接受皮瓣介导关闭的患者中位住院时间为26天(范围13 - 60天),而直接关闭的患者为11天(范围9 - 30天)(p = 0.01)。2例患者(14%)发生伤口感染(Dindo-Clavien II级),而3例患者(21%)因伤口裂开和/或剖腹手术接受了多达7次再次手术(Dindo-Clavien IIIb级)。计算得出的5年生存率为86%。rpT0/T1期患者的生存期明显长于rpT2/T3/T4期肿瘤患者。
复发性SCCA患者的腹会阴联合切除术可提供长期的局部控制和生存。并发症发生率与所采用的关闭技术无关,但接受皮瓣介导关闭的患者住院时间明显更长。